CD13 is a novel mediator of monocytic/endothelial cell adhesion.

TY - JOUR

T1 - CD13 is a novel mediator of monocytic/endothelial cell adhesion.

AU - Mina-Osorio, Paola

AU - Winnicka, Beata

AU - O'Conor, Catherine

AU - Grant, Christina L

AU - Vogel, Lotte K.

AU - Rodriguez-Pinto, Daniel

AU - Holmes, Kathryn V

AU - Ortega, Enrique

AU - Shapiro, Linda H

N1 - Keywords: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD13; Cell Adhesion; Disease Models, Animal; Endothelium, Vascular; Female; Humans; Mice; Mice, Inbred Strains; Monocytes; Peritonitis; Recombinant Proteins; Umbilical Veins

PY - 2008

Y1 - 2008

N2 - During inflammation, cell surface adhesion molecules guide the adhesion and migration of circulating leukocytes across the endothelial cells lining the blood vessels to access the site of injury. The transmembrane molecule CD13 is expressed on monocytes and endothelial cells and has been shown to mediate homotypic cell adhesion, which may imply a role for CD13 in inflammatory monocyte trafficking. Here, we show that ligation and clustering of CD13 by mAb or viral ligands potently induce myeloid cell/endothelial adhesion in a signal transduction-dependent manner involving monocytic cytoskeletal rearrangement and filopodia formation. Treatment with soluble recombinant (r)CD13 blocks this CD13-dependent adhesion, and CD13 molecules from monocytic and endothelial cells are present in the same immunocomplex, suggesting a direct participation of CD13 in the adhesive interaction. This concept is strengthened by the fact that activated monocytic cells adhere to immobilized recombinant CD13. Furthermore, treatment with anti-CD13 antibodies in a murine model of peritonitis results in a decrease in leukocyte infiltration into the peritoneum, suggesting a potential role for CD13 in leukocyte trafficking in vivo. Therefore, this work supports a new direction for CD13 biology, where these cell surface molecules act as true molecular interfaces that induce and participate in critical inflammatory cell interactions.

AB - During inflammation, cell surface adhesion molecules guide the adhesion and migration of circulating leukocytes across the endothelial cells lining the blood vessels to access the site of injury. The transmembrane molecule CD13 is expressed on monocytes and endothelial cells and has been shown to mediate homotypic cell adhesion, which may imply a role for CD13 in inflammatory monocyte trafficking. Here, we show that ligation and clustering of CD13 by mAb or viral ligands potently induce myeloid cell/endothelial adhesion in a signal transduction-dependent manner involving monocytic cytoskeletal rearrangement and filopodia formation. Treatment with soluble recombinant (r)CD13 blocks this CD13-dependent adhesion, and CD13 molecules from monocytic and endothelial cells are present in the same immunocomplex, suggesting a direct participation of CD13 in the adhesive interaction. This concept is strengthened by the fact that activated monocytic cells adhere to immobilized recombinant CD13. Furthermore, treatment with anti-CD13 antibodies in a murine model of peritonitis results in a decrease in leukocyte infiltration into the peritoneum, suggesting a potential role for CD13 in leukocyte trafficking in vivo. Therefore, this work supports a new direction for CD13 biology, where these cell surface molecules act as true molecular interfaces that induce and participate in critical inflammatory cell interactions.

U2 - 10.1189/jlb.1107802

DO - 10.1189/jlb.1107802

M3 - Journal article

C2 - 18495788

SN - 0741-5400

VL - 84

SP - 448

EP - 459

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

IS - 2

ER -